Guerbet
Update in progressGBT.PA (Paris)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Guerbet SA provides contrast media, medical devices, and AI-enabled imaging solutions for diagnostic and interventional radiology worldwide. Its products include DOTAREM and Elucirem gadolinium MRI agents; CT/angiography agents such as Conray, Micropaque, Optiray, Telebrix Gastro, and Xenetix; Lipiodol Ultra Fluid; and a range of delivery injectors and accessories (OptiStar Elite, OptiOne, Illumena Néo). Founded 1901, based in Villepinte, France.
Company score
- Sentiment
- -0.28
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.12
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.12
- Governance
- -0.24
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.05
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.16
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketParis (PAR)
- LocationFrance
- CEOMr. Philippe Bourrinet
- Founded1901
- Employees2,653
- Websitewww.guerbet.com
Identifiers
- ISINFR0000032526
- LEI969500WV1U1WQ059L135